Company Filing History:

6 out of 1,168

Glaxo Group Limited

patents

5 out of 2,198

Smithkline Beecham Corporation

Years Active: 2006-2013

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8575204 - Nicotinamide derivates useful as P38 inhibitors (2013-11-05),

2. 8252818 - Nicotinamide derivatives useful as P38 inhibitors (2012-08-28),

3. 7709506 - Nicotinamide derivatives useful as p38 inhibitors (2010-05-04),

4. 7626055 - Biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors (2009-12-01),

5. 7572790 - Biphenyl carboxylic amide p38 kinase inhibitors (2009-08-11),

6. 7514456 - Nicotinamide derivatives useful as p38 inhibitors (2009-04-07),

7. 7432289 - 5-Acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors (2008-10-07),

8. 7396843 - 5'-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors (2008-07-08),

9. 7309800 - Biphenylcarboxylic amide derivatives as p38 kinase inhibitors (2007-12-18),

10. 7271289 - Biphenylcarboxylic amide derivatives as p38 kinase inhibitors (2007-09-18),

11. 7208629 - 5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors (2007-04-24),

12. 7183297 - Biphenyl-derivatives as p38-kinase inhibitors (2007-02-27),

13. 7151118 - Biphenylcarboxylic amide derivatives as p38-kinase inhibitors (2006-12-19),

14. 7125898 - Nicotinamide derivatives useful as p38 inhibitors. (2006-10-24),

Title: The Innovative Journey of Nicola Mary Aston

Introduction

Nicola Mary Aston is a noteworthy inventor based in Stevenage, GB, recognized for her significant contributions to the field of pharmaceuticals. With a remarkable portfolio comprising 14 patents, Aston focuses her research on creating innovative compounds that hold the potential to address various medical conditions.

Latest Patents

Among her latest innovations are the patents for nicotinamide derivatives that are identified as useful P38 inhibitors. These compounds are meticulously designed to inhibit p38 kinase, playing a crucial role in the treatment of conditions or disease states that are mediated by p38 kinase activity and the cytokines produced by this activity. This advancement showcases Aston's dedication to enhancing therapeutic strategies in pharmacology.

Career Highlights

Nicola Mary Aston has had a profound impact throughout her career, working with leading pharmaceutical companies such as Glaxo Group Limited and SmithKline Beecham Corporation. Her experiences in these reputable organizations have equipped her with the knowledge and skills to pursue groundbreaking research and development in medicinal chemistry.

Collaborations

Collaboration has been an essential aspect of Aston's journey, working alongside talented professionals like Paul Bamborough and Ann Louise Walker. Together, they have contributed to a collaborative environment that fosters innovation and drives forward their research endeavors.

Conclusion

In conclusion, Nicola Mary Aston's body of work exemplifies the essence of ingenuity and collaboration in the field of invention. Her patents reflect her commitment to improving health outcomes through innovation, making her an influential figure in the world of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com

1 patent pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.